Azimuth Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,580
Closed -$238K 282
2019
Q2
$238K Sell
2,580
-204
-7% -$19.4K 0.02% 263
2019
Q1
$263K Sell
2,784
-43,077
-94% -$3.77M 0.02% 260
2018
Q4
$2.94M Sell
45,861
-9,708
-17% -$717K 0.22% 134
2018
Q3
$4.97M Buy
55,569
+1,425
+3% +$126K 0.33% 105
2018
Q2
$4.3M Buy
54,144
+815
+2% +$67.7K 0.31% 114
2018
Q1
$4.76M Sell
53,329
-27,810
-34% -$2.67M 0.35% 106
2017
Q4
$8.47M Sell
81,139
-5,692
-7% -$642K 0.61% 56
2017
Q3
$12.7M Buy
86,831
+230
+0.3% +$31.3K 0.95% 24
2017
Q2
$11.2M Buy
86,601
+2,470
+3% +$303K 0.88% 33
2017
Q1
$10.5M Buy
84,131
+1,035
+1% +$124K 0.84% 34
2016
Q4
$9.62M Buy
83,096
+22,724
+38% +$2.53M 0.82% 42
2016
Q3
$6.31M Buy
60,372
+2,670
+5% +$289K 0.55% 67
2016
Q2
$5.69M Buy
57,702
+3,482
+6% +$360K 0.51% 76
2016
Q1
$5.43M Buy
54,220
+780
+1% +$80.3K 0.52% 75
2015
Q4
$6.4M Buy
53,440
+2,420
+5% +$280K 0.62% 59
2015
Q3
$5.52M Buy
51,020
+390
+0.8% +$48.4K 0.58% 60
2015
Q2
$5.86M Sell
50,630
-20,724
-29% -$2.37M 0.57% 55
2015
Q1
$8.23M Buy
71,354
+2,634
+4% +$315K 0.8% 35
2014
Q4
$7.69M Buy
68,720
+10,930
+19% +$1.15M 0.79% 36
2014
Q3
$5.48M Buy
57,790
+2,931
+5% +$265K 0.6% 57
2014
Q2
$4.71M Sell
54,859
-4,835
-8% -$368K 0.52% 69
2014
Q1
$4.17M Sell
59,694
-15,410
-21% -$1.22M 0.5% 72
2013
Q4
$6.34M Buy
75,104
+1,260
+2% +$99.7K 0.76% 36
2013
Q3
$5.69M Sell
73,844
-2,526
-3% -$177K 0.78% 34
2013
Q2
$4.47M Buy
+76,370
New +$4.6M 0.79% 38

Other funds holding CELG

Azimuth Capital Management's CELG Position: Q3 2019 in Review

Azimuth Capital Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 2,580 shares — an estimated $238K sold.

Azimuth Capital Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $12.7M in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Azimuth Capital Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Azimuth Capital Management sold 2,580 Celgene Corp shares in Q3 2019, an estimated $238K.
  • Azimuth Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Azimuth Capital Management's Celgene Corp position peaked at $12.7M in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Azimuth Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.